查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1479309

免疫蛋白診斷測試的全球市場

Immunoprotein Diagnostic Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球免疫蛋白診斷測試市場預計將達到 203 億美元

免疫蛋白診斷測試的全球市場預計 2023 年為 142 億美元，預計到 2030 年將達到 203 億美元，在 2023-2030 年分析期間複合年成長率為 5.2%。免疫球蛋白診斷測試是本報告分析的細分市場之一，預計複合年成長率為 6%，到分析期結束時將達到 58 億美元。免費輕鏈診斷測試領域預計未來七年複合年成長率為 4.2%。

美國市場預計將成長43億美元，中國複合年成長率為4.8%

預計2023年美國免疫蛋白診斷檢測市場將達43億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到35億美元，2023年至2030年的分析期間複合年成長率為4.8%。其他值得注意的地域市場包括日本和加拿大，預計 2023 年至 2030 年將分別成長 4.9% 和 4.2%。在歐洲，德國的複合年成長率預計約為 4.3%。

2024 年推出令人興奮的新報告功能

完全訪問影響者參與統計數據

免費存取數位檔案和「MarketGlass」研究平台。我們獨特的 MarketGlass 平台使我們能夠集體協作地釋放世界各地專家的創造力和市場知識。我們的尖端工具提供世界一流的市場可視性，同時保護市場參與企業的隱私和身分。報告中的數字、統計數據和市場描述是基於該領域專家和影響者共用的全面見解。

使用即時資料模擬器工具和客製化報告功能參與互動式調查。

客戶全面連結同儕協作互動平台，實現企業間智慧交流

1 年免費報告更新

競爭覆蓋範圍，包括主要參與者的全球市場佔有率

多個地區參與者的市場影響分析（強/活躍/利基/次要）

訪問專家/影響者訪談、播客、新聞公告和活動主題演講的 YouTube 影片

2024 年世界經濟有何預期

貨幣緊縮和相關利率上升導致的地緣政治和經濟不穩定將在 2024 年造成動盪的局面。一些因素將繼續給復甦之路帶來壓力，包括中東的敵對行動和日益頻繁的氣候災害。儘管存在風險，但一些積極因素正在顯現，包括通膨放緩的徵兆更加明顯、對頑固通膨的擔憂有所緩解、供應鏈正常化以及儘管能源成本出現波動但價格仍有所回落。印度和美國等二十一國集團國家的選舉可能會影響資本流動和投資策略。儘管印度作為全球投資目的地的地位日益突出，但在充滿活力的人才和資本生態系統的推動下，美國科技公司將繼續佔據主導地位。儘管該國經濟放緩，但由於國內經濟富有彈性和有利的法規環境，高科技機會（尤其是矽谷）仍然對尋求高成長潛力的投資者俱有吸引力。歐洲持續應對緊縮的貨幣政策和景氣衰退風險，但英國的前景最嚴峻，2024 年景氣衰退的風險最高。中國仍然是通用憑證，其成長預計將受到政府支出和消費者支出改善的支持。動盪的環境可能為投資者和公司帶來機會和挑戰。將波動性視為成長的催化劑，並以敏捷性和策略遠見來制定投資決策，對於生存仍然至關重要。

受訪企業範例（共38家）

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • Ortho Clinical Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP12539

Global Immunoprotein Diagnostic Testing Market to Reach $20.3 Billion by 2030

The global market for Immunoprotein Diagnostic Testing estimated at US$14.2 Billion in the year 2023, is expected to reach US$20.3 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Immunoglobulin Diagnostic Testing, one of the segments analyzed in the report, is expected to record a 6% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Free Light Chain Diagnostic Testing segment is estimated at 4.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 4.8% CAGR

The Immunoprotein Diagnostic Testing market in the U.S. is estimated at US$4.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • Ortho Clinical Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Immunoprotein Diagnostic Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Immunoturbidity Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Immunoturbidity Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Immunoturbidity Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Radioimmunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Endocrine Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Endocrine Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Endocrine Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Allergy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Allergy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Allergy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Immunoprotein Diagnostic Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Immunoprotein Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Immunoprotein Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Immunoglobulin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Immunoglobulin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Immunoglobulin Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Free Light Chain Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Free Light Chain Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Free Light Chain Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Pre-Albumin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Pre-Albumin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Pre-Albumin Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Haptoglobin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Haptoglobin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Haptoglobin Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for C-Reactive Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for C-Reactive Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for C-Reactive Protein Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Complement System Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Complement System Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: World 16-Year Perspective for Complement System Protein Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Enzyme-Linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Enzyme-Linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: World 16-Year Perspective for Enzyme-Linked Immunosorbent Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Immunoprotein Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Immunoprotein Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: World 16-Year Perspective for Immunoprotein Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Autoimmune Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Autoimmune Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: World 16-Year Perspective for Autoimmune Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 62: USA Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • CHINA
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: China 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: China 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: China 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Immunoprotein Diagnostic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 110: France Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: France 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: France 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: France 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 164: Rest of World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of World Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of World 16-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of World Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of World 16-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of World Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of World 16-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2014, 2024 & 2030

IV. COMPETITION